| Literature DB >> 31234803 |
Côme Tholomier1,2, Yifan Wang1, Olga Aleynikova3, Tsafrir Vanounou1, Jean-Sebastien Pelletier4.
Abstract
BACKGROUND: Biliary mucinous cystic neoplasms are rare cystic lesions of the liver which carry pre-malignant potential. Given the scarcity of reports in the literature, they pose a considerable challenge to clinical management, particularly with regards to accurate pre-operative diagnosis. CASEEntities:
Keywords: Biliary cystadenoma; Biliary mucinous cystic neoplasm; Hydatid disease; Investigation; Management
Year: 2019 PMID: 31234803 PMCID: PMC6591873 DOI: 10.1186/s12876-019-1001-5
Source DB: PubMed Journal: BMC Gastroenterol ISSN: 1471-230X Impact factor: 3.067
Fig. 1CT scan with oral and intravenous contrast in axial (1a and 1b) and coronal (1c and 1d) views, demonstrating a multi-loculated cystic mass embedded within segments V and VIII of the liver and causing deviation of the right portal vein. Arrows pointing towards the partially calcified septations
Fig. 2Gross morphology of the biliary mucinous cystic neoplasm (2a, 2b and 2c)
Fig. 3Light microscopy of the biliary mucinous cystic neoplasm showing the ovarian-type stroma with hematoxylin and eosin stain (3a). Immunohistochemical staining using Cytokeratin 19 (3b), estrogen receptor protein (3c) and CD10 (3d) highlighting the epithelium and ovarian stroma present in cystadenomas
Review of contemporary published case series on biliary mucinous cystic neoplasms with more than 10 cases
| N | Sex | Age (years) | Size cm (mean) | Previous intervention | Operative Procedure and recurrences | Follow-up | |
|---|---|---|---|---|---|---|---|
| Vogt et al. (2005) [ | 18 | 48 | 12.5 (7–22) | 10 patients (55%) | Enucleation [ | Mean: 37 months | |
| Partial excision [ | Sectionectomy [ |
| |||||
| Aspiration [ | Hepatectomy [ | ||||||
| Roux-en-Y [ | Partial resection [ | ||||||
| Thomas et al. (2005) [ | 18 BCA 1 BCAC | 48 | 10.9 ± 4.4 | 8 patients (42% | Lobectomy [ | Mean: 3.5 ± 4.2 years | |
| Aspiration or drainage [ | Enucleation [ | No mortality or recurrence | |||||
| Fenestration [ | Bisegmentectomy [ | ||||||
| Roux-en-Y [ | Non-anatomic resection [ | ||||||
| Fenestration + fulguration [ | |||||||
| Daniels et al. (2006) [ | 12 | 50.5 | 12.7 (6.5–25) | 5 patients (42%) | Enucleation + complete resection [ | Unknown duration of follow-up | |
| Drainage [ | Enucleation [ | No mortality or recurrence | |||||
| Roux-en-Y [ | Complete resection [ | ||||||
| Choi et al. (2010) [ | 17 | 57 | 10.1 ± 6.6 | Unknown | Hepatectomy [ | N/A | |
| Unroofing or marsupialization [ | |||||||
| Erdogan et al. (2010) [ | 12 BCA 3 BCAC | 45 | 8.4 ± 5.3 (3–19) | Unknown | Enucleation [ | No early post-operative mortality | |
| Hepatectomy [ | |||||||
| Seo et al. (2010) [ | 13 | 55.3 ± 11.4 | 12.9 ± 6.3 | None | Complete resection [ | Median: 29 months | |
| No mortality or recurrence | |||||||
| Sang et al. (2011) [ | 19 | 44.2 ± 14.4 | 13.0 ± 8.1 | 5 patients (26%) | Hemihepatectomy [ | Median: 22.5 months | |
| Aspiration [ | Sectionectomy [ |
| |||||
| Fenestration [ | Segmentectomy [ | No recurrence | |||||
| Enucleation [ | |||||||
| Fenestration [ | |||||||
| Martel et al. (2012) [ | 11 BCA 2 BCAC | 51 ± 15.9 | 12.4 ± 4.6 | None | Enucleation [ | Median: 23.1 months | |
| Unroofing [ |
| ||||||
|
| |||||||
| Liver resection [ | |||||||
| Pillai et al. (2012) [ | 13 | 46 | (23–34) | 7 (54%) | Hepatectomy [ | Median: 22 months | |
| Partial cystoperi- | Segmentectomy [ | No mortality or recurrence | |||||
| cystectomies [ | Enucleation [ | ||||||
| Marsupialisaton [ | |||||||
| Fenestration [ | |||||||
| Ratti et al. (2012) [ | 12 | 45 ± 9.4 | N/A | 6/12 (50%) ➔ Unroofing followed by complete resection after post-op diagnosis (median delay of 31 days) | Hepatectomy [ | Median: 16 months | |
| Lobectomy [ | No mortality or recurrence | ||||||
| Wang et al. (2012) [ | 20 | 44.2 ± 13.1 | 13.0 (4.4–32) | Unknown | Liver resection [ | N/A | |
| Chen et al. (2014) [ | 35 BCA 4 BCAC | 53.7 ± 14.5 | N/A | None | Enucleation [ | Median: 20.5 months | |
| Hepatectomy [ |
| ||||||
| No mortality or recurrence for BCA | |||||||
| Wang et al. (2014) [ | 13 BCA 1 BCAC | 48 | 10.4 ± 6.3 | None | Lobectomy [ | Median: 54 months | |
|
| |||||||
| Hepatectomy [ | No mortality or recurrence for BCA | ||||||
| Partial hepatic resection [ | |||||||
| Non-anatomic resection [ | |||||||
| Albores-Saavedra et al. (2015) [ | 18 BCA 2 BCAC | 38.2 | 11 (4–29) | None | Enucleation [ | Range 2–11 years | |
| Lobectomy [ |
| ||||||
| Whipple resection [ | |||||||
| Local excision [ | |||||||
| Lee et al. (2015) [ | 19 | 57 | 8.5 (2.5–21) | None | Complete resection: anatomic or enucleation [ | Median: 51.3 months | |
| Partial resection: fenestration, marsupialization, partial excision [ | Median DFS: 3.7 months (for partial resection) | ||||||
| Arnaoutakis et al. (2015) [ | 221 | 51.2 ± 15.1 | Median: 10.0 IQR: 7–13 | Cyst aspiration (19.8%) Sclerosis (2%) | Partial hepatectomy (116, 52.5%) | 10-year follow-up: 84% patients alive with BCA 31/221 (16.7%) | |
| Hepatectomy (70, 31.7%) – | |||||||
| Total: 248 BCAC: 27 | Unroofing/partial excision (34, 15.4%) – | recurrences 50 (22.6%) early post-operative complications | |||||
| Liver transplant (1, 0.4%) |
BCA Biliary cystadenoma (biliary mucinous cystic neoplasia), BCAC Biliary cystadenocarcinoma (biliary mucinous cystic neoplasia with invasive carcinoma), DFS Disease-free survival, OS Overall survival, RFS Relapse-free survival, F Female, M Male, MI Myocardial Infarction, IQR Inter-quartile range
Full articles are available via PubMed and originally in English
When possible, biliary cystadenocarcinoma cases were removed from analysis given focus of this manuscript on biliary cystadenoma